Sailaja Puttagunta
Chief Tech/Sci/R&D Officer at ITERUM THERAPEUTICS PLC
Net worth: 15 968 $ as of 2024-03-30
Sailaja Puttagunta active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ITERUM THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 2021-12-12 | - |
Career history of Sailaja Puttagunta
Former positions of Sailaja Puttagunta
| Companies | Position | Start | End |
|---|---|---|---|
| BIOMX INC. | Chief Tech/Sci/R&D Officer | 2019-10-27 | 2021-12-12 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Chief Tech/Sci/R&D Officer | 2018-11-30 | 2019-09-30 |
| ITERUM THERAPEUTICS PLC | Corporate Officer/Principal | 2015-12-31 | 2018-11-30 |
| ALLERGAN PLC | Chief Tech/Sci/R&D Officer | 2014-12-31 | 2015-12-31 |
| DURATA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 2012-05-31 | 2014-11-30 |
Training of Sailaja Puttagunta
| Gandhi Medical College & Hospital | Undergraduate Degree |
| New York University School of Medicine | Graduate Degree |
Statistics
International
| Ireland | 3 |
| Israel | 3 |
| United States | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 5 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ITERUM THERAPEUTICS PLC | Health Technology |
| BIOMX INC. | Health Technology |
| Private companies | 3 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Stock Market
- Insiders
- Sailaja Puttagunta
- Experience
